recent
emerg
novel
human
coronaviru
late
wuhan
region
china
rapidli
evolv
global
pandem
infect
million
peopl
worldwid
april
th
high
transmiss
rate
high
proport
asymptomat
infect
led
massiv
worldwid
need
rapid
afford
effici
diagnost
test
perform
clinic
nonclin
set
current
wide
use
method
detect
clinic
diagnost
rtqpcr
assay
detect
presenc
viral
rna
patient
sampl
although
rtqpcr
wide
implement
detect
pathogen
includ
virus
clinic
sampl
implement
specif
assay
detect
recent
establish
current
use
protocol
develop
optim
detect
novel
coronaviru
univers
hospit
collabor
sever
laboratori
germani
netherland
china
franc
uk
belgium
addit
exist
protocol
optim
center
diseas
control
cdc
unit
state
comprehens
comparison
valid
altern
avail
kit
nucleic
acid
extract
use
altern
probe
primer
set
effici
detect
clinic
sampl
routin
applic
qpcr
rel
quantif
transcript
interest
sampl
preced
isol
total
rna
sampl
b
use
purifi
rna
reversetranscript
rt
reaction
result
complementari
dna
cdna
templat
rna
util
qpcr
reaction
howev
nucleic
acid
purif
rt
result
rna
cdna
labori
timeconsum
addit
step
requir
manual
handl
result
experiment
error
case
clinic
sampl
diagnost
use
singlereact
kit
combin
rt
qpcr
reaction
taqpath
rtqpcr
therefor
customari
although
singlestep
rtqpcr
remov
need
separ
rt
reaction
rna
isol
clinic
sampl
constitut
signific
chokepoint
diagnost
process
remain
manual
labori
expens
specif
univers
hospit
cdc
protocol
requir
use
rna
purif
kit
result
signific
cost
increas
alreadi
led
major
suppli
shortag
kit
therefor
crucial
new
test
afford
quick
effici
keep
use
industri
kit
minimum
recent
attempt
made
circumv
rna
extract
detect
establish
routin
rnaextractionfre
singlereact
rtqpcr
test
fig
heatinactiv
nasopharyng
swab
sampl
transport
medium
compar
result
clinic
diagnos
patient
sampl
demonstr
viabil
extractionfre
diagnost
addit
provid
data
show
rtqpcr
perform
presenc
high
concentr
deterg
allow
test
directli
sampl
lysat
importantli
method
build
clinic
establish
protocol
could
easili
integr
expand
ongo
test
pipelin
also
modular
incorpor
altern
approach
utilis
pcr
start
investig
transport
media
use
swab
collect
affect
rtqpcr
spike
synthet
fullgenom
rna
twist
bioscienc
dilut
seri
three
differ
transport
media
virocult
sigma
transwab
sigma
eswab
copan
use
clinic
sampl
time
studi
karolinska
univers
hospit
stockholm
sweden
mock
sampl
contain
synthet
grna
copi
medium
correspond
medium
rtqpcr
reaction
perform
singlereact
rtqpcr
use
sampl
taqpath
reaction
cdc
nucleocapsid
primerprob
set
tabl
method
record
cycl
threshold
c
valu
dilut
seri
media
observ
inhibitori
effect
three
media
importantli
pronounc
variat
media
fig
virocult
transwab
demonstr
similar
profil
inhibit
result
ct
highest
medium
concentr
fig
minim
inhibit
concentr
medium
rtqpcr
reaction
eswab
complet
imped
detect
high
concentr
reach
similarli
low
level
inhibit
virocult
transwab
concentr
reaction
rt
experi
reli
synthet
rna
vital
exclud
possibl
linger
dna
templat
molecul
therefor
addit
perform
rt
qpcr
reaction
two
separ
step
method
includ
rtcontrol
demonstr
lack
dna
amplif
signal
revers
transcriptas
elimin
reaction
supplementari
fig
togeth
result
indic
minim
inhibit
virocult
transwab
eswab
rtqpcr
reaction
correspond
sampl
rtqpcr
reaction
test
whether
direct
rtqpcr
could
correctli
detect
presenc
absenc
clinic
sampl
obtain
five
aliquot
nasopharyng
swab
sampl
store
transport
medium
aliquot
sampl
previous
clinic
diagnos
use
convent
rna
extract
magna
pure
dna
viral
na
sv
kit
roch
diagnost
follow
rtqpcr
call
three
patient
sampl
posit
two
neg
viru
clinic
diagnost
perform
karolinska
univers
hospit
stockholm
inactiv
nasopharyng
sampl
either
ad
magna
pure
extern
lysi
buffer
roch
use
convent
rna
purif
heat
min
perform
rtqpcr
use
sampl
observ
lack
amplif
posit
sampl
inactiv
extern
lysi
buffer
fig
supplementari
fig
howev
rtqpcr
perform
directli
heatinactiv
sampl
correctli
detect
posit
sampl
lack
signal
neg
sampl
control
fig
indic
viabil
explor
heatinactiv
direct
rtqpcr
hidrtqpcr
method
detect
clinic
sampl
also
test
twostep
rt
qpcr
detect
clinic
sampl
method
correctli
detect
viral
presenc
absenc
supplementari
fig
next
test
primerprob
set
perform
hidrtqpcr
use
nasopharyng
swab
sampl
primersprob
set
target
gene
rnadepend
rna
polymeras
rdrp
envelop
e
nucleocapsid
tabl
obtain
addit
heatinactiv
min
nasopharyng
swab
sampl
call
posit
previou
clinic
diagnost
method
observ
set
modest
differ
rdrp
hidrtqpcr
mean
median
ct
differ
wilcoxon
signedrank
test
egen
set
appear
consider
higher
ct
valu
primerprob
set
mean
median
ct
differ
wilcoxon
signedrank
test
fig
lower
perform
primer
probe
target
e
gene
line
previou
result
argu
short
amplicon
target
optim
heatinactiv
sampl
consider
amplicon
length
could
less
import
pcr
amplif
perform
extract
rna
fresh
sampl
see
discuss
due
superior
perform
rdrp
hidrtqpcr
focus
primer
analys
dilut
experi
medium
spikein
synthet
rna
shown
limit
inhibit
medium
reaction
fig
howev
clinic
sampl
contain
addit
materi
swab
unknown
potenti
inhibitori
agent
addit
due
potenti
larg
variabl
clinic
sampl
import
character
inhibit
curv
multipl
individu
clinic
sampl
rather
averag
mix
sampl
optim
amount
sampl
input
hidrtqpcr
balanc
possibl
inhibit
sampl
amount
rna
go
reaction
identifi
optim
rang
sampl
input
clinic
sampl
perform
dilut
seri
individu
posit
heatinactiv
min
nasopharyng
swab
sampl
found
input
sampl
taqpath
rtqpcr
optim
avoid
sharp
inhibitori
effect
higher
amount
sampl
input
observ
individu
sampl
yet
minim
c
fig
evalu
whether
direct
rtqpcr
heatinactiv
sampl
might
allow
effect
sensit
diagnost
perform
heat
inactiv
min
aliquot
clinic
diagnos
nasopharyng
sampl
perform
hidrtqpcr
blindli
statu
sampl
use
input
primer
rdrp
well
rnase
p
assess
sampl
rna
integr
thereaft
combin
result
hidrtqpcr
ct
valu
clinic
diagnost
perform
extract
rna
magna
pure
roch
diagnost
test
target
e
rdrp
fig
observ
strong
correl
ct
valu
extract
heatinactiv
sampl
fig
ct
valu
hidrtqpcr
sampl
higher
rna
eluat
sampl
median
ct
differ
fig
expect
given
rna
load
eluat
standard
input
vs
volum
equival
hidrtqpcr
rna
extract
eluat
perform
fresh
sampl
aliquot
use
hidrtqpcr
frozen
store
thaw
heat
inactiv
heat
may
degrad
rna
presenc
rnase
andor
metal
ion
metalionbas
rna
cleavag
inhibitori
agent
swab
medium
may
inhibit
rtqpcr
although
signific
medium
inhibit
unlik
fig
ij
perform
rna
reextract
freezethaw
aliquot
compar
c
valu
eluat
match
fresh
sampl
found
effect
freezethaw
result
ct
fig
howev
differ
ct
valu
differ
diagnost
outcom
ie
detect
presenc
absenc
plot
heatmap
ct
valu
fig
found
strike
agreement
clinic
diagnost
perform
rna
eluat
hidrtqpcr
call
absentorpres
call
qpcr
analysi
depend
arbitrari
cyclenumb
cutoff
appli
high
cutoff
may
valid
especi
pcr
effici
expect
low
individu
sampl
hand
one
posit
sampl
hidrtqpcr
detect
amplif
record
ct
fig
sampl
notabl
use
diagnost
extract
rna
bestperform
target
rdrp
refer
hidrtqpcr
use
primerprob
set
show
accuraci
confid
interv
p
x
binomin
test
sensit
specif
tabl
among
case
hidrtqpcr
use
rdrp
miss
three
posit
sampl
detect
routin
diagnost
rna
eluat
target
gene
e
rdrp
interestingli
three
sampl
identifi
posit
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
hidrtqpcr
rdrp
neg
routin
diagnost
extract
rna
fig
sampl
note
two
patient
retest
collect
new
swab
sampl
clinic
day
origin
routin
diagnost
confirm
posit
ct
e
rdrp
correct
hidrtqpcr
accuraci
sensit
specif
take
retest
account
tabl
altogeth
data
suggest
hidrtqpcr
may
viabl
option
extractionbas
diagnost
want
stress
procedur
optim
implement
see
discuss
workabl
suggest
fomsgaard
et
al
report
higher
rna
yield
lower
ct
valu
sampl
heatinactiv
compar
lower
temperatur
step
refin
compar
heat
inactiv
five
clinic
sampl
observ
median
improv
minu
ct
rdrp
set
respect
p
onesid
wilcoxon
signedrank
test
fig
even
direct
rout
test
might
run
rtqpcr
unpurifi
swab
sampl
even
saliva
lyse
directli
rtqpcr
sar
coronaviru
capsid
selfassembl
particl
lipid
bilay
weak
spot
thu
viral
capsid
ruptur
surfact
time
viral
rna
releas
similarli
lyse
human
cell
sampl
rtqpcr
assay
directli
detergentinactiv
sampl
would
requir
rtqpcr
assay
resili
high
concentr
deterg
determin
effect
rtqpcr
use
spikein
copi
synthet
fullgenom
rna
twist
bioscienc
primerprob
set
found
c
valu
modestli
affect
ct
incub
much
triton
rtqpcr
reaction
fig
observ
lower
level
fluoresc
plateau
phase
qpcr
increas
concentr
deterg
without
markedli
affect
ct
fig
step
test
whether
could
detect
direct
lysi
obtain
six
aliquot
saliva
six
combin
nose
throat
swab
pb
six
deidentifi
donor
method
four
identifi
posit
two
neg
extractionbas
routin
diagnost
sampl
aliquot
obtain
public
health
agenc
sweden
notabl
sampl
collect
health
care
profession
use
clinic
grade
flock
plastic
swab
rather
sampl
selfcollect
use
simpl
cotton
swab
deposit
pb
jar
without
storag
buffer
saliva
method
furthermor
time
experi
sampl
freezethaw
store
room
temperatur
sever
hour
combin
test
sampl
blindli
mix
sampl
saliva
nose
throat
swab
triton
perform
rtqpcr
use
primer
probe
directli
lysat
inde
four
posit
donor
individu
correctli
call
posit
least
one
triton
condit
sampl
saliva
andor
nose
throat
swab
neg
control
lack
signal
fig
initi
encourag
result
indic
effort
optim
detergentinactiv
direct
rtqpcr
detect
worthwhil
scale
rapid
afford
diagnost
could
help
limit
spread
potenti
save
mani
live
rna
extract
constitut
barrier
scaleup
test
explor
method
circumv
rna
extract
perform
rtqpcr
directli
heatinactiv
subject
sampl
sampl
lysat
result
show
rtqpcrbase
test
infect
perform
significantli
simpler
protocol
without
use
rna
extract
kit
special
kit
result
also
suggest
might
achiev
without
major
sacrific
accuraci
determin
neg
posit
case
procedur
could
especi
use
massiv
scale
test
logist
cost
rna
purif
could
unwork
mass
test
importantli
direct
method
also
attract
set
repeat
cheaper
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
quicker
test
desir
exampl
frequent
test
healthcar
personnel
determin
rtqpcr
inhibit
profil
differ
transport
media
well
optim
amount
reaction
input
nasopharyng
swab
sampl
fig
effort
invest
similar
character
mani
brand
type
transport
media
circul
propos
character
rt
pcr
inhibit
becom
standard
requir
commerci
viral
bacteri
transport
media
futur
assist
direct
test
forthcom
epidem
ongo
pandem
question
whether
suitabl
deposit
sampl
convent
transport
medium
instead
suggest
swab
materi
collect
buffer
inhibit
rtqpcr
especi
viral
cultur
lab
meaning
vast
major
sampl
blind
test
clinic
sampl
found
hidrtqpcr
cdc
primerprobeset
larg
agre
convent
extractionbas
diagnost
target
gene
e
rdrp
fig
tabl
c
valu
hidrtqpcr
overal
inferior
higher
compar
convent
extractionbas
rtqpcr
detect
howev
suggest
lower
analyt
sensit
hidrtqpcr
method
improv
sensit
hidrtqpcr
heatinactiv
procedur
promptli
optim
maxim
rna
integr
sampl
effect
inactiv
viru
other
found
brief
inactiv
high
temperatur
provid
higher
rna
yield
compar
longer
heatinactiv
lower
temperatur
addit
suggest
ad
chelat
edta
heat
metalionbas
rna
cleavag
heat
could
reduc
supplement
mgcl
rtqpcr
reaction
may
compens
lower
avail
mg
need
revers
transcript
moreov
medium
could
buffer
lower
ph
better
preserv
phosphodiest
bond
rna
heat
chemic
heat
resist
rnase
inhibitor
may
increas
sensit
hidrtqpcr
addit
heat
resist
readili
avail
chemic
rnase
inhibitor
cheap
make
suitabl
scale
diagnost
although
effect
rtqpcr
need
character
other
combin
effort
identifi
optim
heatinactiv
formula
hidrtqpcr
heatinactiv
expect
cleav
rna
shorter
fragment
suggest
primer
probe
consider
hidrtqpcr
could
import
sensit
extractionbas
rtqpcr
intact
rna
accordingli
observ
primerprob
set
shortest
amplicon
perform
best
hidrtqpcr
longest
amplicon
e
perform
worst
fig
conclus
short
amplicon
target
use
hidrtqpcr
follow
also
hypothes
direct
rtqpcr
pipelin
test
might
made
even
effici
sampl
directli
lysi
buffer
contain
deterg
triton
contain
chemic
rnase
inhibitor
ph
rna
stabil
lyse
sampl
could
taken
immedi
rtqpcr
analysi
dilut
rtqpcr
master
mix
without
interven
step
although
data
limit
procedur
need
refin
result
saliva
nosethroat
sampl
use
cotton
swab
fig
suggest
strategi
workabl
sensit
ultim
prove
adequ
meaning
decis
selfisol
limit
spread
method
could
appli
sampl
taken
testsubject
open
path
massiv
screen
popul
fig
selfcollect
sampl
volunt
clinic
screen
perform
stockholm
area
organ
public
health
agenc
sweden
swab
sampl
nose
throat
two
cotton
tip
wooden
swab
use
instruct
provid
via
written
note
introduc
one
swab
throat
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
via
chin
far
back
throat
possibl
scrape
rins
swab
provid
buffer
instruct
also
given
take
second
wooden
swab
introduc
nose
scrape
nostril
follow
rins
buffer
tube
throat
swab
buffer
swab
test
pb
ph
instruct
leav
saliva
sampl
time
spit
time
small
jar
period
sampl
pick
transport
laboratori
test
typic
within
sampl
sampl
store
rna
extract
within
test
use
rtqpcr
current
studi
sampl
deidentifi
aliquot
sampl
subsequ
frozen
approxim
day
thaw
kept
room
temperatur
perform
direct
lysi
experi
describ
herein
work
use
anonym
pseudoanonym
surplu
materi
sampl
collect
clinic
diagnost
inform
consent
obtain
patient
accord
swedish
act
concern
ethic
review
research
involv
human
allow
develop
improv
diagnost
assay
use
patient
sampl
collect
perform
test
question
onestep
rtqpcr
revers
transcript
quantit
pcr
use
onestep
taqpath
rtqpcr
master
mix
thermo
accord
manufactur
instruct
total
reaction
form
mix
taqpath
master
mix
primersprob
mix
sampl
rnase
free
water
fill
reaction
primer
probe
concentr
rtqpcr
reaction
follow
e
rdrp
primer
probe
rdrp
primer
probe
primer
probe
sequenc
list
tabl
thermal
cycl
step
c
min
c
c
cycl
c
c
rtqpcr
perform
steponeplu
real
time
pcr
machin
appli
biosystem
use
stepon
softwar
sampl
selftest
screen
fig
subject
protocol
describ
without
heat
inactiv
briefli
sampl
swab
sampl
pb
pure
saliva
mix
equal
volum
triton
room
temperatur
approxim
dilut
taqpath
rtqpcr
master
mix
describ
clinic
diagnost
karolinska
univers
hospit
stockholm
sweden
similarli
perform
use
taqpath
primer
probe
e
rdrp
rna
eluat
sampl
twostep
rtqpcr
revers
transcript
perform
mix
subject
sampl
dntp
random
hexam
thermo
rnase
inhibitor
takara
triton
rnase
free
water
follow
incub
c
sampl
place
ice
mix
contain
dtt
betain
rnase
inhibitor
takara
superscript
ii
buffer
superscript
ii
invitrogen
water
ad
sampl
incub
c
follow
c
final
c
amplif
cdna
rt
mix
use
primer
probe
describ
tabl
perform
use
biotaq
dna
polymeras
biolin
reaction
contain
reaction
buffer
biolin
dntp
mix
water
thermal
cycl
step
c
c
c
cycl
c
c
qpcr
perform
steponeplu
real
time
pcr
machin
appli
biosystem
use
stepon
softwar
gel
electrophoresi
product
rtqpcr
separ
electrophoresi
agaros
gel
buffer
length
product
determin
rel
ultralow
rang
dna
ladder
thermo
imag
taken
use
imagequ
camera
system
intent
work
clinic
method
develop
respons
emerg
work
use
anonym
pseudoanonym
surplu
materi
sampl
collect
clinic
diagnost
accord
swedish
act
concern
ethic
review
research
involv
human
allow
develop
improv
diagnost
assay
use
patient
sampl
collect
perform
test
question
khattari
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
made
sampl
barcod
highthroughput
dna
sequenc
fg
unlik
wide
use
approach
includ
rna
step
c
use
industri
rna
kit
direct
sampl
circumv
process
instead
clinic
sampl
deposit
transport
medium
viral
either
direct
lysi
detergentcontain
buffer
sampl
use
downstream
rtqpcr
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
freezethaw
xaxi
extract
sampl
use
e
gene
cross
rdrp
star
primerprob
set
nd
detect
c
heatmap
ct
perform
clinic
sampl
use
extract
rna
e
rdrp
hidrtqpcr
rdrp
rank
egen
ct
control
rna
rtqpcr
rnase
p
transcript
sampl
show
right
two
mark
asterisk
hidrtqpcr
later
retest
confirm
see
result
mark
ring
retest
three
sampl
mark
hash
call
primerset
hidrtqpcr
boxplot
ct
increas
nasopharyng
swab
sampl
min
versu
min
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
e
barplot
ct
rtqpcr
use
primerprov
set
perform
directli
lyse
donor
sampl
storag
freez
thaw
selfsampl
saliva
nasal
throat
swab
suspens
taken
wooden
without
percent
triton
indic
percentag
deterg
sampl
half
rtqpcr
cross
indic
ct
valu
perform
extract
rna
fresh
aliquot
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
tabl
accuraci
sensit
specif
hidrtqpcr
use
rtqpcr
extract
rna
refer
show
retest
reclassifi
patient
neg
first
clinic
diagnosi
see
result
primerprob
set
use
comparison
within
bracket
binomin
test
pvalu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
